Eupraxia Pharma's (NASDAQ: EPRX) DiffuSphere technology has shown promising results in targeted drug delivery for cancer treatment. The company recently announced that its novel technology demonstrated successful targeted delivery of a chemotherapeutic agent to tumors in animal models.
Key Highlights
Targeted Drug…